{"id":"https://genegraph.clinicalgenome.org/r/c28a8d2b-91dc-47b4-9b6c-daebe6057d56v1.0","type":"EvidenceStrengthAssertion","dc:description":"ERBB4 was first reported in relation to autosomal dominant amyotrophic lateral sclerosis 19 (meaning amyotrophic lateral sclerosis caused by variants in the ERBB4 gene rather than a distinct ALS phenotype) in 2013 (Takahashi et al., PMID:24119685). Amyotrophic lateral sclerosis (ALS) is a progressive, neurodegenerative disease involving death or loss of function of upper and lower motor neurons. ERBB4 is a membrane-bound receptor tyrosine kinase which binds ligands such as neuregulin, dimerises, usually with ErbB2 or ErbB3, and auto-phosphorylates on activation. At least 19 unique ERBB4 variants have been reported in humans. Evidence supporting this gene-disease relationship includes case-level and experimental data.\n\n2.9 points have been given for variants in this gene which have been reported in at least 7 publications (PMIDs: 24119685; 32065797; 32166880; 33414559; 31788332; 31432357; 28889094). The seminal paper (Takahashi et al., 2013 PMID:24119685) identified ERBB4 as a candidate gene in a family of 3 affected siblings, based on an assumption of reduced penetrance. A de novo variant in ERBB4 in a person with sporadic ALS was identified as part of this study. Other publications consist of a case study of an individual with ALS-FTD, and genetic epidemiology studies involving genotyping people enrolled in specialist ALS clinics and screening for variants in known or implicated ALS genes.\nThe mechanism for disease is unknown.\nThis gene-disease association is supported by an immunohistochemistry study (PMID: 31124187) investigating ErbB4 expression in the central nervous system of people with sporadic ALS compared to non-neuro disease controls and neuro disease controls. The study showed there was reduced ErbB4 in motor neurons correlating with severity of motor neuron loss, that the subcellular localization of ErbB4 was altered in people with sporadic ALS â€“ ErbB4 was found in the nucleolus, in spheroids (previously associated with ALS pathogenicity) and in glial cells. There was a negative correlation between pathogenic subcellular localization of TDP-43 and presence of ErbB4 in motor neurons. ERBB4 mouse knock-out models produce an altered neuronal phenotype, but not an ALS phenotype (PMIDs: 14555954; 12824469; 15543145; 15976301).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/c28a8d2b-91dc-47b4-9b6c-daebe6057d56","GCISnapshot":"https://genegraph.clinicalgenome.org/r/fdd26ab6-0c1f-4322-9f70-cad651bb789f","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/fdd26ab6-0c1f-4322-9f70-cad651bb789f_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10096","date":"2021-10-01T21:58:32.695Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/fdd26ab6-0c1f-4322-9f70-cad651bb789f_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10096","date":"2021-09-30T14:31:44.993Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fdd26ab6-0c1f-4322-9f70-cad651bb789f_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04366e59-5eb8-41a3-9fd9-a0a07232b453","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04366e59-5eb8-41a3-9fd9-a0a07232b453_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31432357","allele":{"id":"https://genegraph.clinicalgenome.org/r/3d633167-5646-493f-9885-52215787bc9f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005235.3(ERBB4):c.206A>T (p.Glu69Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA350783610"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/64838885-6851-4210-8c40-e9c387b87507","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/64838885-6851-4210-8c40-e9c387b87507_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reduced phosphorylation of variant erbb-4 compared to wild-type using NRG1 stimulation","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/64838885-6851-4210-8c40-e9c387b87507_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32065797","allele":{"id":"https://genegraph.clinicalgenome.org/r/a62296f7-515d-4807-bcc6-6061b38b8eb7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005235.3(ERBB4):c.2136T>G (p.Ile712Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2087836"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/833a81aa-7c65-4f47-97cb-71f136510f34","type":"EvidenceLine","dc:description":"High allele count in gnomAD v2.1.1 non-neuro","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/833a81aa-7c65-4f47-97cb-71f136510f34_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32166880","allele":{"id":"https://genegraph.clinicalgenome.org/r/11498192-8726-4f38-880b-030abc448a33","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005235.3(ERBB4):c.283C>T (p.Arg95Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2088471"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/245819ab-4ea8-4891-8f68-96b03c8c2ef5","type":"EvidenceLine","dc:description":"Lowered the score as the functional evidence is already scored for Ped3166/II-4 ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/245819ab-4ea8-4891-8f68-96b03c8c2ef5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reduced autophosphorylation","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/245819ab-4ea8-4891-8f68-96b03c8c2ef5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24119685","allele":{"id":"https://genegraph.clinicalgenome.org/r/49a4fc0a-2849-4984-844c-bd37c101b03b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005235.3(ERBB4):c.2780G>A (p.Arg927Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA216500"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a8231a3e-e7e4-45b2-8b2f-ce7c6dea9558","type":"EvidenceLine","dc:description":"High allele count in gnomAD v2.1.1 non-neuro ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a8231a3e-e7e4-45b2-8b2f-ce7c6dea9558_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32166880","allele":{"id":"https://genegraph.clinicalgenome.org/r/df0812a9-70db-43b1-8311-96905fbf696b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005235.3(ERBB4):c.1624G>A (p.Glu542Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2088066"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/59a6a773-384c-4caf-82a6-e065228f37a9","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59a6a773-384c-4caf-82a6-e065228f37a9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33414559","allele":{"id":"https://genegraph.clinicalgenome.org/r/f51a795a-e1f8-4cdd-9bc2-9147f8e7e42f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005235.3(ERBB4):c.3814G>A (p.Gly1272Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/976654"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a10475d6-e0c1-43e2-ba23-4ace99e2d997","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a10475d6-e0c1-43e2-ba23-4ace99e2d997_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reduced autophosphorylation.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a10475d6-e0c1-43e2-ba23-4ace99e2d997_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24119685","allele":{"id":"https://genegraph.clinicalgenome.org/r/b18dd80f-87fd-4003-aafc-850f588c9a73","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005235.3(ERBB4):c.3823C>T (p.Arg1275Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA216502"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/8a3646f7-d385-4397-9187-0f85afc5efcd","type":"EvidenceLine","dc:description":"From paper in relation to people with ERBB4 variants \"Two and one of the 11 patients are also included in the STEX and C9orf72 groups, respectively.\" which variants this refers to is not made clear so 3 variants that would have been scored at the default 0.1 were chosen to have a score of 0.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a3646f7-d385-4397-9187-0f85afc5efcd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32166880","allele":{"id":"https://genegraph.clinicalgenome.org/r/1f9b20a2-633d-4002-8036-dc585ce44a12","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005235.3(ERBB4):c.2342T>C (p.Val781Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA350781465"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/150cd5bf-f182-43ea-abfa-40367f8abc6f","type":"EvidenceLine","dc:description":"High allele count in gnomAD v2.2.1 non-neuro","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/150cd5bf-f182-43ea-abfa-40367f8abc6f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32166880","allele":{"id":"https://genegraph.clinicalgenome.org/r/5ddbb5c2-a4a1-4f09-90a2-966a279da005","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005235.3(ERBB4):c.3400G>A (p.Val1134Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2087452"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/fdc9bff9-e412-4cad-8458-5a14d3b746e2","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fdc9bff9-e412-4cad-8458-5a14d3b746e2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reduced autophosphorylation shown by immunoblot analysis with antibodies against phospho-ErbB4 (Tyr1284). ERBB4 is a receptor tyrosine kinase - homodimerization on activation by neuregulins is followed by autophosphorylation.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/fdc9bff9-e412-4cad-8458-5a14d3b746e2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24119685","allele":{"id":"https://genegraph.clinicalgenome.org/r/49a4fc0a-2849-4984-844c-bd37c101b03b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e8fa4526-0fb2-4cdf-81a8-3e5a2ecfd1aa","type":"EvidenceLine","dc:description":"From paper in relation to people with ERBB4 variants \"Two and one of the 11 patients are also included in the STEX and C9orf72 groups, respectively.\" which variants this refers to is not made clear so 3 variants that would have been scored at the default 0.1 were chosen to have a score of 0.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e8fa4526-0fb2-4cdf-81a8-3e5a2ecfd1aa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32166880","allele":{"id":"https://genegraph.clinicalgenome.org/r/1063660e-f169-41be-9037-28a5d1cfa9cb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005235.3(ERBB4):c.1927A>G (p.Thr643Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA350782845"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/cb6e1e16-6bbe-41fa-8a5c-89f8b7907d36","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cb6e1e16-6bbe-41fa-8a5c-89f8b7907d36_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32166880","allele":{"id":"https://genegraph.clinicalgenome.org/r/10fbdcd8-1a76-46b5-94c0-3acdeb27554e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005235.3(ERBB4):c.1967G>A (p.Gly656Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA350782736"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/eb82049d-6795-4c6a-9ebe-12fa45193186","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb82049d-6795-4c6a-9ebe-12fa45193186_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32166880","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b5a67b8-4ef3-41fa-ae04-39e36aa3d36e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005235.3(ERBB4):c.3107C>G (p.Thr1036Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA350777927"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/2a71f06e-920d-4216-99f9-c324b6274d03","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a71f06e-920d-4216-99f9-c324b6274d03_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31788332","allele":{"id":"https://genegraph.clinicalgenome.org/r/2f351f72-8951-4ba9-ac51-59527ceb9965","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005235.3(ERBB4):c.965T>A (p.Met322Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA350443688"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/fdd26ab6-0c1f-4322-9f70-cad651bb789f_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9561483a-ba19-4b2f-af2d-8b73ca1b7530_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24119685","rdfs:label":"Ped255","family":{"id":"https://genegraph.clinicalgenome.org/r/9561483a-ba19-4b2f-af2d-8b73ca1b7530","type":"Family","rdfs:label":"Ped255","member":{"id":"https://genegraph.clinicalgenome.org/r/14382a7c-0edd-4ef6-92ef-6f359af2a010","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24119685","rdfs:label":"III-1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":67,"allele":{"id":"https://genegraph.clinicalgenome.org/r/49a4fc0a-2849-4984-844c-bd37c101b03b"},"detectionMethod":"The full gene was sequenced but there is no information about testing to exclude variants in other ALS genes.","firstTestingMethod":"Sanger sequencing","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/245819ab-4ea8-4891-8f68-96b03c8c2ef5_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/14382a7c-0edd-4ef6-92ef-6f359af2a010"}},{"id":"https://genegraph.clinicalgenome.org/r/7b74671a-a821-4a45-993c-41cd74ff5f11_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24119685","rdfs:label":"Ped5175","family":{"id":"https://genegraph.clinicalgenome.org/r/7b74671a-a821-4a45-993c-41cd74ff5f11","type":"Family","rdfs:label":"Ped5175","member":{"id":"https://genegraph.clinicalgenome.org/r/a084356a-0bf7-437c-aa77-5d48b89dbb01","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24119685","rdfs:label":"II-1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":45,"allele":{"id":"https://genegraph.clinicalgenome.org/r/b18dd80f-87fd-4003-aafc-850f588c9a73"},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a10475d6-e0c1-43e2-ba23-4ace99e2d997_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/a084356a-0bf7-437c-aa77-5d48b89dbb01"}},{"id":"https://genegraph.clinicalgenome.org/r/ee5dc19c-852b-4ce1-999d-aac7bcd7f76f_proband_segregation","type":"FamilyCosegregation","dc:description":"Only 2 reported segregations.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24119685","rdfs:label":"Ped3166","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/ee5dc19c-852b-4ce1-999d-aac7bcd7f76f","type":"Family","rdfs:label":"Ped3166","member":{"id":"https://genegraph.clinicalgenome.org/r/31ceee5a-159d-4b2e-ab90-a915c2392dd4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24119685","rdfs:label":"II-4","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":63,"allele":{"id":"https://genegraph.clinicalgenome.org/r/49a4fc0a-2849-4984-844c-bd37c101b03b"},"firstTestingMethod":"Next generation sequencing panels","previousTesting":true,"previousTestingDescription":"Mutational analysis of the proband (II-4) employing direct nucleotide sequence analysis, a microarray-based resequencing, or a repeat-primed PCR analysis excluded SOD1[MIM 147450], ALS2[MIM 606352], DCTN1[MIM 601143], CHMP2B[MIM 609512], ANG[MIM 105850], TARDBP[MIM 605078], FUS[MIM 137070] and C9ORF72[MIM 1614260] as the genes associated with FALS.","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/fdc9bff9-e412-4cad-8458-5a14d3b746e2_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/31ceee5a-159d-4b2e-ab90-a915c2392dd4"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/32e9c4fb-5054-4ceb-bd35-fba31e87c5a3","type":"EvidenceLine","dc:description":"From paper in relation to people with ERBB4 variants \"Two and one of the 11 patients are also included in the STEX and C9orf72 groups, respectively.\" which variants this refers to is not made clear so 3 variants that would have been scored at the default 0.1 were chosen to have a score of 0.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/32e9c4fb-5054-4ceb-bd35-fba31e87c5a3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32166880","allele":{"id":"https://genegraph.clinicalgenome.org/r/f680abdc-bf2d-4908-92d6-d093069235d5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005235.3(ERBB4):c.19C>T (p.Leu7Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA350784046"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d9bf9a5c-4187-48c4-8801-6a25524478a9","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9bf9a5c-4187-48c4-8801-6a25524478a9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33414559","allele":{"id":"https://genegraph.clinicalgenome.org/r/70bc3b4f-ee80-4d17-bb9d-9a6086de1555","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005235.3(ERBB4):c.3176T>C (p.Met1059Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2087514"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/3670305d-9e0a-4406-9012-e07035c92efd","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3670305d-9e0a-4406-9012-e07035c92efd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28889094","allele":{"id":"https://genegraph.clinicalgenome.org/r/5eee37fd-efb5-4a06-8d82-800d1f6d3a46","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005235.3(ERBB4):c.1997T>C (p.Ile666Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2087889"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b4e3ac7b-d920-4349-b9b3-dfadcb405288","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b4e3ac7b-d920-4349-b9b3-dfadcb405288_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32166880","allele":{"id":"https://genegraph.clinicalgenome.org/r/4a9f2dac-17c7-496b-8460-333267822800","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005235.3(ERBB4):c.3685A>G (p.Met1229Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2087380"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/076c8bc9-acab-4060-803e-f67541c8a95e","type":"EvidenceLine","dc:description":"From paper in relation to people with ERBB4 variants \"Two and one of the 11 patients are also included in the STEX and C9orf72 groups, respectively.\" which variants this refers to is not made clear. In addition the variant as described in the paper is ambiguous - the variant selected for the curation is our best interpretation of the variant as described.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/076c8bc9-acab-4060-803e-f67541c8a95e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32166880","allele":{"id":"https://genegraph.clinicalgenome.org/r/629309c1-acb5-426f-a4cf-67b5ed72dc5f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000002.12:g.211387997T>C (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2087518"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c7c73183-525a-42a1-8d97-065d43253d9e","type":"EvidenceLine","dc:description":"High frequency in gnomAD-non neuro (v2.1.1) ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7c73183-525a-42a1-8d97-065d43253d9e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33414559","allele":{"id":"https://genegraph.clinicalgenome.org/r/49fbb119-e77e-4956-a559-ee8da0707e22","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005235.3(ERBB4):c.1122T>G (p.His374Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/770696"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":2.9},{"id":"https://genegraph.clinicalgenome.org/r/fdd26ab6-0c1f-4322-9f70-cad651bb789f_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fdd26ab6-0c1f-4322-9f70-cad651bb789f_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/97dea8e1-504c-4b27-9b9d-6f40dec8f493","type":"EvidenceLine","dc:description":"Although erbB4 interacts with neuregulin, a protein implicated in the pathogenesis of ALS the functional effect of neuregulin is not known so the evidence has been added to the curation for information but is not strong enough to be scored.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8529c85d-8596-4a73-bd85-0ed2317cc830","type":"Finding","dc:description":"NRG1 expression changes have been associated with ALS in mouse models and through quantification on human ALS spinal cords. NRG1 binds to erbB4 membrane receptors, which causes erbB4 to heterodimerize with erbB2 and transduce the signal via tyrosine phosphorylation. Increased erbB2 activation in microglia of ALS mice correlates with disease progression. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22249457","rdfs:label":"NRG1 in ALS","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/72fd6f09-6e25-49c4-ad60-59a7bd5ab475","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/51d643ad-1df0-42fb-960c-21e7e7e05d55","type":"Finding","dc:description":"Loss of ErbB4 immunoreactivity in motor neurons from CNS tissue in some people. Where immunoreactivity was seen ErbB4 was mis-localized - for example being localized in the nucleus, some times as threads or dots. Glial and spheroid immunoreactivity also recorded. Sub-cellular TDP-43 staining and ErbB4 immunoreactivity was negatively correlated. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31124187","rdfs:label":"Dysregulation of ErbB4 immunoreactivity in the motor neurons","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5}],"evidenceStrength":"Limited","sequence":3443,"specifiedBy":"GeneValidityCriteria8","strengthScore":3.4,"subject":{"id":"https://genegraph.clinicalgenome.org/r/8b1PJThjKJI","type":"GeneValidityProposition","disease":"obo:MONDO_0014223","gene":"hgnc:3432","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_fdd26ab6-0c1f-4322-9f70-cad651bb789f-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}